November 16 from 5:45 pm – 7:45 pm EST
University of DC/Catholic University Room | Supported By: Eli Lilly & Company
Program Description
Join us for an in-depth discussion led by three distinguished rheumatologists and a leading endocrinologist specializing in obesity as they explore the impact of obesity on inflammatory rheumatic conditions.
Learning objectives:
- Explore the prevalence of obesity in rheumatic diseases
- Examine the role of obesity as a driver of systemic inflammation and its impact on PsA
- Discuss shared decision-making from the rheumatologist and endocrinologist perspective
This program is developed and offered by Eli Lilly and Company. This is not an official program of the American College of Rheumatology.
Speakers
Atul Deodhar, MD
Professor of Medicine, Medical Director of Rheumatology Clinics
Oregon Health & Science University
Portland, Oregon
Alexis Ogdie, MD
Associate Professor of Medicine and Epidemiology
University of Pennsylvania – Perelman School of Medicine
Philadelphia, Pennsylvania
Orrin Troum, MD
Director of Rheumatology Clinical Research
Providence Saint John’s Health Center
Santa Monica, California
Willa Hsueh, MD
Director, Diabetes and Metabolism Research Center
Wexner Medical Center
Columbus, Ohio